Booster immunization of antigen primed mice with anti-idiotypic T cells generates antigen-specific memory T cell response

Vaccine

Volumn 24, Issue 8, 2006, Pages 1149-1158

  Lal, Girdhari ^a   Shaila, M S ^a   Nayak, Rabindranath ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

Anti idiotypic T cells; Idiopeptide; Peptidomimics; Relay hypothesis; T cell memory

Indexed keywords

ANTIBIOTIC AGENT; ANTIIDIOTYPIC ANTIBODY; NUCLEOCAPSID PROTEIN; PHOSPHOPROTEIN; T LYMPHOCYTE RECEPTOR;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; BONE MARROW; CATTLE PLAGUE VIRUS; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; LYMPHOCYTE CLONE; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; MALE; MICE; MICE, INBRED BALB C; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 32044456923     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.099     Document Type: Article

References (56)

1. P.C. Beverley Is T cell memory maintained by cross-reactive stimulation Immunol Today 11 1990 203 205
2. C.D. Surch, and J. Sprent Homeostatic T cell proliferation: how far can T cells be activated to self ligands J Exp Med 192 2001 F9 F14
3. J. Sprent T cell survival and role of cytokines Immunol Cell Biol 79 2001 199 206
4. R.M. Zinkernagel On natural and artificial vaccinations Annu Rev Immunol 21 2003 515
5. S. Sad, and L. Krishnan Maintenance and attrition of T-cell memory Crit Rev Immunol 23 2003 129 147
6. R. Nayak, S. Mitra-Kaushik, and M.S. Shaila Perpetuation of immunological memory: a relay hypothesis Immunology 102 2001 387 395
7. R. Nayak, G. Lal, and M.S. Shaila Perpetuation of immunological memory: role of serum antibodies and accessory cells Microbes Infect 7 2005 1276 1283
8. S. Mitra-Kaushik, M.S. Shaila, A. Karande, and R. Nayak Idiotypic-anti-idiotypic B cell interactions generated against a protective antigen of a morbillivirus in mice Cell Immunol 209 2001 10 18
9. S. Mitra-Kaushik, M.S. Shaila, A. Karande, and R. Nayak Idiotype and antigen-specific T cell responses in mice on immunization with antigen, antibody, and anti-idiotypic antibody Cell Immunol 209 2001 109 119
10. S. Mitra-Kaushik, M.S. Shaila, A. Karande, and R. Nayak Idiotype and anti-idiotype specific T cell responses on transplantation with hybridomas reactive to viral hemagglutinin and human tumor antigen Immunol Lett 80 2002 81 87
11. B. Monzavi-Karbassi, G. Cunto-Amesty, P. Luo, and T. Kieber-Emmons Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery Trends Biotechnol 20 2002 207 214
12. + cells recognizing epitope of the T cells receptor beta-chain from a myelin basic protein specific T cell clone Eur J Immunol 23 1993 530
13. F. Zipp, M. Kerschensteiner, K. Dornmair, J. Malotka, S. Schmidt, and A. Bender Diversity of anti-TCR immune response and its implications for T cell vaccination therapy of multiple sclerosis Brain 121 1998 1395 1407
14. N.K. Jerne Towards the network theory of the immune system Ann Immunol (Inst Pasture) 125c 1974 373 389
15. J. Hong, Y.C. Zang, M.V. Tejada-Simon, S. Li, V.M. Rivera, and J. Killian Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell vaccination J Immunol 165 2000 6858 6864
16. K. Ohishi, K. Inui, K. Yamanouchi, and T. Barrett Cell mediated immune response in cattle vaccinated with a vaccinia virus recombinant expressing the nucleocapsid protein of Rinderpest virus J Gen Virol 80 1999 1627 1634
17. S. Mitra-Kaushik, R. Nayak, and M.S. Shaila Identification of a cytotoxic T-cell epitope on the recombinant nucleocapsid proteins of rinderpest and peste des petits ruminants viruses presented as asS.E.M.bled nucleocapsids Virology 279 2001 210 220
18. R. Kaushik, and M.S. Shaila Cellular casein kinase II-mediated phosphorylation of rinderpest virus P protein is a prerequisite for its role in replication/transcription of the genome J Gen Virol 85 3 2004 687 691
19. F.W. Fitch, and T.F. Gajewski Production of T cell clone J.E. Coligan A.M. Kruisbeek D.H. Margulish E.M. Shevach W. Strober Current protocols in immunology 1 1992 John Wiley and Sons New York 3.13
20. A. Saha, S.K. Chattarjee, K.A. Foon, J.F. Primus, and M. Bhattacharya-Chatterjee Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective anti-tumor immunity Cancer Res 63 2003 2844 2854
21. Z. Cai, and J. Sprent Resting and activated T cells display different requirements for CD8 molecules J Exp Med 179 1994 2005 2015
22. K. Murali-Krishna, J.D. Altman, M. Suresh, D.J.D. Sourdive, A.J. Zajac, and J.D. Miller Counting antigen specific CD8 T cells: a reevaluation of by stander activation during viral infection Immunity 8 1998 177 187
23. M. Bellone, G. Lezzi, P. Revere, G. Galati, A. Ronchetti, and M.P. Protti Processing of engulfed apoptotic bodies yields T cell epitopes J Immunol 159 1997 5391 5399
24. A. Propato, G. Cutrona, V. Francavilla, M. Ulivi, E. Schiaffella, and O. Landt Apoptotic cells over express vinculin and induce vinculin specific cytotoxic T-cell cross priming Nat Med 7 2001 807 813
25. E. Mougneau, S. Hugues, and N. Glaichenhaus Antigen presentation by dendritic cells in vivo J Exp Med 196 2002 1013 1016
26. L. Adorini, S.J. Ullrich, E. Appella, and S. Fuchs Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells Nature 346 1990 63 66
27. + T cell division in irradiated mice requires peptides distinct from those responsible for thymic selection J Exp Med 190 1999 367 373
28. Y.C. Zang, J. Hong, V.M. Rivera, J. Killian, and J.Z. Zhang Preferential recognition of TCR hyper-variable regions by human alpha-idiotypic T cells induced by T cell vaccination J Immunol 164 2000 4011 4017
29. R. Medaer, P. Stinissen, L. Truyen, J. Raus, and J. Zhang Depletion of myelin-basic-protein autoreactive T cells by T cell vaccination: pilot trial in multiple sclerosis Lancet 346 1995 807 808
30. O. Lider, T. Reshef, E. Beraud, A. Ben-Nun, and I. Cohen Anti-idiotypic network induced by T cell vaccination against experimental auto-immune encephalomyelitis Science 239 1988 181 183
31. J. Zhang, C. Vandevyver, P. Stinissen, and J. Raus In vivo clonotypic regulation of human myelin basic protein reactive T cells by T cell vaccination J Immunol 155 1995 5868 5877
32. Y.C. Zang, J. Hong, V.M. Rivera, J. Killian, and J.Z. Zhang Human anti-idiotypic T cells induced by TCR peptide corresponding to a common CDR3 sequence motif in myelin basic protein-reactive T cells Int Immunol 15 2003 1073 1080
33. J. Zhang, R. Medaer, P. Stinissen, D. Hafler, and J. Raus MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination Science 261 1993 1451 1454
34. I.R. Cohen T cell vaccination for auto-immune disease: a panorama Vaccine 20 2002 706 710
35. E.J. Wherry, and R. Ahmed Memory CD8 T cell differentiation during viral infection J Virol 78 2004 5535 5545
36. J. Sprent, and D.F. Tough T cell death and memory Science 293 2001 245 248
37. M.L. Albert, B. Sauter, and N. Bhardwaj Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs Nature 392 1998 86 89
38. A. Ronchetti, P. Rovere, G. Iezzi, G. Galati, S. Heltai, and M.P. Protti Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen presenting cells and cytokines J Immunol 163 1999 130 136
39. K. Kurosaka, M. Takahashi, N. Watanabe, and Y. Kobayashi Silent cleanup of very early apoptotic cells by macrophages J Immunol 171 2003 4672 4679
40. V. Barnaba, C. Watts, M. de Boer, P. Lane, and A. Lanzavecchia Professional presentation of antigen by activated human T cells Eur J Immunol 24 1994 71 75
41. G. Lal, M.S. Shaila, and R. Nayak Activated mouse T cells synthesize MHC class II, process and present morbillivirus nucleocapsid protein to primed T cells Cell Immunol 234 2005 133 145
42. Reits EAJ, J.C. Vos, M. Gromme, and J. Neefjes The major substrate for TAP in vitro are derived from newly synthesized protein Nature 404 2000 774 778
43. U. Schubert, L.C. Anton, J. Gibbs, C.C. Norbury, J.W. Yewdell, and J.R. Bennink Rapid degradation of a large fraction of newly synthesized proteins by proteasomes Science 404 2000 770 774
44. J.P. Lauritsen, M.D. Christensen, J. Dietrich, J. Kastrup, N. Odum, and C. Geisler Two distinct pathways exist for down regulation of the TCR J Immunol 161 1998 260 267
45. J. Dietrich, C. Menne, J.P. Lauritsen, M. von Essen, A.B. Rasmussen, and N. Odum Ligand-induced TCR down-regulation is not dependent on constitutive TCR recycling J Immunol 168 2002 5434 5440
46. S. Valitutti, S. Muller, M. Salio, and A. Lanzavecchia Degradation of T cell receptor (TCR)-CD3-ζ complexes after antigenic stimulation J Exp Med 185 1997 1859 1864
47. E.S. Jose, and B. Alarcon Receptor engagement transiently diverts the T cell receptor heterodimer from a constitutive degradation pathway J Biol Chem 274 1999 33740 33746
48. V. Kumar Homeostatic control of immunity by TCR peptide specific tregs J Clin Invest 144 2004 1222 1226
49. I.R. Cohen, F.J. Owintana, and A. Mimimran Tregs in T cell vaccination: exploring the regulation of regulation J Clin Invest 114 2004 1227 1232
50. β8.2 chain control murine experimental auto-immune encephalomyelitis J Immunol 154 1995 1941 1950
51. A.A. Vandenbark, Y.K. Chou, R. Whitham, M. Mass, A. Buenafe, and D. Liefeld Treatment of multiple sclerosis with T cell receptor peptides: results of a double blind pilot trial Nat Med 2 1996 1109 1115
52. V. Kumar, and E. Sercarz T cell regulatory capacity:antigen specific and TCR idiopeptide specific T cell interaction in EAE Int Rev Immunol 9 1993 287 297
53. K.C. Garcia, M. Degano, L.R. Pease, M. Huang, P.A. Peterson, and L. Teyton Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen Science 279 1998 1166 1172
54. E.C. de Haan, E.E. Moret, J.P. Wagenaar-Hilbers, R.M. Liskamp, and M.H. Wauben Possibilities and limitations the rational design of modified peptides for T cell mediated immunotherapy Mol Immunol 42 2005 365 373
55. E.C. de Haan, J.P. Wagenaar-Hilbers, R.M. Liskamp, E.E. Moret, and M.H. Wauben Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides Mol Immunol 42 2005 355 364
56. F.C. Westall Molecular mimicry or structural mimicry? Mol Immunol 43 2006 1062 1064